Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 DNA repair: a double-edged sword.

× No keyword cloud information.

19 in total

1. The prognostic value of ERCC1 expression in gastric cancer patients treated with platinum-based chemotherapy: a meta-analysis.

Authors: Kong-Kong Wei; Lei Jiang; Yao-Yao Wei; Yu-Feng Wang; Xuan-Kun Qian; Qiang Dai; Quan-Lin Guan
Journal: Tumour Biol Date: 2014-05-29

2. Genetic polymorphisms in XPG could predict clinical outcome of platinum-based chemotherapy for advanced non-small cell lung cancer.

Authors: Weicai Hu; Jinbing Pan; Pu Zhao; Guangyu Yang; Shujuan Yang
Journal: Tumour Biol Date: 2014-03-11

Review 3. Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis.

Authors: Shu-zhen Wei; Ping Zhan; Mei-qi Shi; Yi Shi; Qian Qian; Li-ke Yu; Yong Song
Journal: Med Oncol Date: 2010-02-09 Impact factor: 3.064

4. Systematic evaluation of genetic variants in three biological pathways on patient survival in low-stage non-small cell lung cancer.

Authors: V Shane Pankratz; Zhifu Sun; Jeremiah Aakre; Yan Li; Cassandra Johnson; Yolanda I Garces; Marie C Aubry; Julian R Molina; Dennis A Wigle; Ping Yang
Journal: J Thorac Oncol Date: 2011-09 Impact factor: 15.609

5. Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy.

Authors: Xifeng Wu; Charles Lu; Yuanqing Ye; Joe Chang; Hushan Yang; Jie Lin; Jian Gu; Waun Ki Hong; David Stewart; Margaret R Spitz
Journal: Pharmacogenet Genomics Date: 2008-11 Impact factor: 2.089

Review 6. Reversing mitochondrial dysfunction, fatigue and the adverse effects of chemotherapy of metastatic disease by molecular replacement therapy.

Authors: Garth L Nicolson; Kenneth A Conklin
Journal: Clin Exp Metastasis Date: 2007-12-05 Impact factor: 5.150

7. DNA repair gene polymorphisms and clinical outcome of patients with primary small cell carcinoma of the esophagus.

Authors: Qiang Zhou; Bing-Wen Zou; Yong Xu; Jian-Xin Xue; Mao-Bin Meng; Fang-Jiu Liu; Lei Deng; Dai-Yuan Ma; Rui Ao; You Lu
Journal: Tumour Biol Date: 2014-11-06

8. Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer.

Authors: Giannis Mountzios; Meletios-Athanasios Dimopoulos; Christos Papadimitriou
Journal: Biomark Insights Date: 2008-04-17

9. The effects of ERCC1 expression levels on the chemosensitivity of gastric cancer cells to platinum agents and survival in gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.

Authors: Yong-Ping Liu; Yang Ling; Qiu-Feng Qi; Ya-Ping Zhang; Chang-Song Zhang; Chang-Tai Zhu; Mei-Hua Wang; Yao-Dong Pan
Journal: Oncol Lett Date: 2012-12-28 Impact factor: 2.967

10. Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer.

Authors: Yan Du; Tong Su; Lijun Zhao; Xiaojie Tan; Wenjun Chang; Hongwei Zhang; Guangwen Cao
Journal: PLoS One Date: 2014-06-16 Impact factor: 3.240